Cogent Biosciences, Inc.

Historical 13F Holders

Symbol
COGT
CUSIP
19240Q201
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 17 1.88 M $11.3 M
2024 Q4 184 122 M $949 M
2024 Q3 167 122 M $1.32 B
2024 Q2 159 123 M $1.04 B
2024 Q1 161 113 M $760 M
2023 Q4 156 94.3 M $554 M
2023 Q3 140 90.9 M $886 M
2023 Q2 138 88.5 M $1.05 B
2023 Q1 139 75.3 M $814 M
2022 Q4 143 79.2 M $914 M
2022 Q3 143 76.4 M $1.13 B
2022 Q2 123 70.9 M $639 M
2022 Q1 89 47.8 M $358 M
2021 Q4 84 48.1 M $413 M
2021 Q3 74 36.8 M $310 M
2021 Q2 72 40.1 M $324 M
2021 Q1 71 37.7 M $331 M
2020 Q4 69 33.5 M $376 M